Corticotropin-releasing hormone treatment for major depression Joachim F. Hallmayer Clinical Trials Report Pages: 163 - 164
Mifepristone treatment for psychotic depression Joachim F. Hallmayer Clinical Trials Report Pages: 164 - 165
The stress-vulnerability hypothesis in psychotic disorders: Focus on the stress response systems Christine C. Gispen-de WiedLucres M. C. Jansen OriginalPaper Pages: 166 - 170
Corticosteroids, immune suppression, and psychosis Dana C. PerantieE. Sherwood Brown OriginalPaper Pages: 171 - 176
Stimulant-induced psychosis and schizophrenia: The role of sensitization Hiroshi Ujike OriginalPaper Pages: 177 - 184
Postpartum psychoses: Prognosis, risk factors, and treatment Bruno PfuhlmannGerald StoeberHelmut Beckmann OriginalPaper Pages: 185 - 190
Selective serotonin reuptake inhibitors and the risk of developing myocardial infarction Prakash S. Masand Clinical Trials Report Pages: 199 - 199
Selective serotonin reuptake inhibitors and the risk of developing myocardial infarction Prakash S. Masand Clinical Trials Report Pages: 199 - 199
Selective serotonin reuptake inhibitors and the platelet aggregation Prakash S. Masand Clinical Trials Report Pages: 200 - 201
Delirium: An important (but often unrecognized) clinical syndrome Terry Rabinowitz OriginalPaper Pages: 202 - 208
Mood disorders and chronic obstructive pulmonary disease: Current research and future needs Greg L. ClaryScott M. PalmerP. Murali Doraiswamy OriginalPaper Pages: 213 - 221
Pharmacologic treatment of mood disorders in acquired immune deficiency syndrome (AIDS) Jordan KlesmerRuxandra Badescu OriginalPaper Pages: 222 - 227
Neuropsychiatric aspects of human immunodeficiency virus (HIV) infection Francisco Fernandez OriginalPaper Pages: 228 - 231
